{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:16:11Z","timestamp":1780542971233,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gastric cancer after\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (HP) eradication is a crucial clinical challenge today as HP eradication therapy is widely performed. Detecting gastric cancer after HP eradication tends to be difficult with normal white-light endoscopy. In the present study, we aimed to identify easily-evaluated endoscopic findings that indicate the presence of gastric cancer after HP eradication so that endoscopists can consider additional detailed examinations at the site.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the endoscopic images of 43 patients who underwent endoscopic submucosal dissection for early gastric cancer after HP eradication and 119 patients with an HP eradication history who underwent esophagogastroduodenoscopy for a medical checkup. Endoscopic findings were evaluated according to the Kyoto classification of gastritis (atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness) and map-like redness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with gastric cancer had significantly higher total Kyoto risk scores; more atrophy, intestinal metaplasia, and diffuse redness; and a significantly higher prevalence of map-like redness compared with those without gastric cancer, in the univariate analyses. We used logistic regression analysis with forward selection based on the likelihood ratio to develop a model using atrophy and diffuse redness. Receiver operating characteristic analysis showed that a score of A2 in the Kyoto classification of gastritis (open-type atrophic pattern in the Kimura\u2013Takemoto classification) was an endoscopic marker for the presence of post-HP-eradication gastric cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endoscopic severe gastric mucosal atrophy is useful to screen patients for gastric cancer after HP eradication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01375-z","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T07:03:32Z","timestamp":1595228612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Endoscopic severe mucosal atrophy indicates the presence of gastric cancer after Helicobacter pylori eradication -analysis based on the Kyoto classification"],"prefix":"10.1186","volume":"20","author":[{"given":"Akiko","family":"Ohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Yatagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunori","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-5141","authenticated-orcid":false,"given":"Tadakazu","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"6","key":"1375_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1375_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to helicobacter pylori. Int J Cancer. 2015;136(2):487\u201390.","journal-title":"Int J Cancer"},{"issue":"3","key":"1375_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/aje\/kwh039","volume":"159","author":"H Brenner","year":"2004","unstructured":"Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol. 2004;159(3):252\u20138.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1375_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s101200200001","volume":"5","author":"S Kikuchi","year":"2002","unstructured":"Kikuchi S. Epidemiology of helicobacter pylori and gastric cancer. Gastric Cancer. 2002;5(1):6\u201315.","journal-title":"Gastric Cancer"},{"issue":"9636","key":"1375_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet (London, England). 2008;372(9636):392\u20137.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"1375_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","volume":"150","author":"YC Lee","year":"2016","unstructured":"Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150(5):1113\u201324 e1115.","journal-title":"Gastroenterology"},{"issue":"3","key":"1375_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"1","author":"K Kimura","year":"1969","unstructured":"Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1(3):87\u201396.","journal-title":"Endoscopy"},{"issue":"10","key":"1375_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1994","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston. American J Surgical Pathol 1996. 1994;20(10):1161\u201381.","journal-title":"American J Surgical Pathol 1996"},{"issue":"3","key":"1375_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1746.1991.tb01469.x","volume":"6","author":"GN Tytgat","year":"1991","unstructured":"Tytgat GN. The Sydney system: endoscopic division. Endoscopic appearances in gastritis\/duodenitis. J Gastroenterol Hepatol. 1991;6(3):223\u201334.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1375_CR10","first-page":"982","volume":"112","author":"T Kamada","year":"2015","unstructured":"Kamada T, Haruma K, Inoue K, Shiotani A. Helicobacter pylori infection and endoscopic gastritis -Kyoto classification of gastritis. Nihon Shokakibyo Gakkai zasshi. 2015;112(6):982\u201393.","journal-title":"Nihon Shokakibyo Gakkai zasshi"},{"issue":"6","key":"1375_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2169\/internalmedicine.56.7775","volume":"56","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto M, Ban H, Ichikawa H, Sahara S, Otsuka T, Inatomi O, Bamba S, Furuta T, Andoh A. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer. Internal Med (Tokyo, Japan). 2017;56(6):579\u201386.","journal-title":"Internal Med (Tokyo, Japan)"},{"issue":"3","key":"1375_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/jgh.12839","volume":"30","author":"K Yoon","year":"2015","unstructured":"Yoon K, Kim N, Nam RH, Suh JH, Lee S, Kim JM, Lee JY, Kwon YH, Choi YJ, Yoon H, et al. Ultimate eradication rate of helicobacter pylori after first, second, or third-line therapy in Korea. J Gastroenterol Hepatol. 2015;30(3):490\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1375_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.kjms.2016.04.009","volume":"32","author":"S Shinozaki","year":"2016","unstructured":"Shinozaki S, Nomoto H, Kondo Y, Sakamoto H, Hayashi Y, Yamamoto H, Lefor AK, Osawa H. Comparison of vonoprazan and proton pump inhibitors for eradication of helicobacter pylori. Kaohsiung J Med Sci. 2016;32(5):255\u201360.","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"1375_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/ajg.2008.15","volume":"104","author":"AC de Vries","year":"2009","unstructured":"de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol. 2009;104(6):1342\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1375_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/jgh.12687","volume":"30","author":"S Jung","year":"2015","unstructured":"Jung S, Park CH, Kim EH, Shin SJ, Chung H, Lee H, Park JC, Shin SK, Lee YC, Lee SK. Preventing metachronous gastric lesions after endoscopic submucosal dissection through helicobacter pylori eradication. J Gastroenterol Hepatol. 2015;30(1):75\u201381.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1375_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2036.2005.02360.x","volume":"21","author":"M Ito","year":"2005","unstructured":"Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, Egi Y, Kitadai Y, Yasui W, Yoshihara M, et al. Morphological changes in human gastric tumours after eradication therapy of helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005;21(5):559\u201366.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"1375_CR17","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00535-013-0764-7","volume":"48","author":"M Kobayashi","year":"2013","unstructured":"Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Sato Y, Ajioka Y, Aoyagi Y. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after helicobacter pylori eradication. J Gastroenterol. 2013;48(12):1332\u201342.","journal-title":"J Gastroenterol"},{"issue":"7","key":"1375_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10552-008-9132-y","volume":"19","author":"R Ladeiras-Lopes","year":"2008","unstructured":"Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689\u2013701.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"1375_CR19","first-page":"203","volume":"4","author":"N Nagata","year":"2011","unstructured":"Nagata N, Shimbo T, Akiyama J, Nakashima R, Kim HH, Yoshida T, Hoshimoto K, Uemura N. Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy. Gastroenterology Res. 2011;4(5):203\u20139.","journal-title":"Gastroenterology Res"},{"issue":"27","key":"1375_CR20","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.3748\/wjg.v19.i27.4374","volume":"19","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Nagata N, Nakashima R, Furuhata E, Shimbo T, Kobayakawa M, Sakurai T, Imbe K, Niikura R, Yokoi C, et al. Predictive findings for helicobacter pylori-uninfected, \u2212infected and -eradicated gastric mucosa: validation study. World J Gastroenterol. 2013;19(27):4374\u20139.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1375_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41395-018-0259-5","volume":"114","author":"K Kaji","year":"2019","unstructured":"Kaji K, Hashiba A, Uotani C, Yamaguchi Y, Ueno T, Ohno K, Takabatake I, Wakabayashi T, Doyama H, Ninomiya I, et al. Grading of atrophic gastritis is useful for risk stratification in endoscopic screening for gastric Cancer. Am J Gastroenterol. 2019;114(1):71\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1375_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/hel.12184","volume":"20","author":"M Okuda","year":"2015","unstructured":"Okuda M, Osaki T, Lin Y, Yonezawa H, Maekawa K, Kamiya S, Fukuda Y, Kikuchi S. Low prevalence and incidence of helicobacter pylori infection in children: a population-based study in Japan. Helicobacter. 2015;20(2):133\u20138.","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"1375_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/hel.12257","volume":"20","author":"E Roma","year":"2015","unstructured":"Roma E, Miele E. Helicobacter pylori infection in pediatrics. Helicobacter. 2015;20(Suppl 1):47\u201353.","journal-title":"Helicobacter"},{"issue":"7","key":"1375_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/00365520500463175","volume":"41","author":"PE Arkkila","year":"2006","unstructured":"Arkkila PE, Seppala K, Farkkila MA, Veijola L, Sipponen P. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol. 2006;41(7):782\u201390.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"1375_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1440-1746.2009.05995.x","volume":"25","author":"T Toyokawa","year":"2010","unstructured":"Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M. Eradication of helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol. 2010;25(3):544\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1375_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.gie.2016.03.791","volume":"84","author":"S Shichijo","year":"2016","unstructured":"Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T, Fukayama M, Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618\u201324.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"1375_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00535-012-0536-9","volume":"47","author":"S Take","year":"2012","unstructured":"Take S, Mizuno M, Ishiki K, Imada T, Okuno T, Yoshida T, Yokota K, Oguma K, Kita M, Okada H, et al. Reinfection rate of helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol. 2012;47(6):641\u20136.","journal-title":"J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01375-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T19:40:49Z","timestamp":1626723649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01375-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01375-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-21765\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was performed in accordance with the guidelines of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Kyorin University School of Medicine (IRB No. 1353) on September 5, 2019. Informed consent was obtained using an opt-out method with a written notice. Administrative permission was not required to access and use the medical records described in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}